Market Vectors® Biotech ETF (BBH)

Delayed Data
As of Apr 20
 +0.69 / +0.52%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors ® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for Market Vectors® Biotech ETF.


1 month-1.88% 3 years+45.42%
3 months+8.71% 5 years--
1 year+54.52% Since inception+48.88%
Data through 04/18/2015

Quote Details

Previous close$132.01
Open day’s range-- – --
Net asset value (NAV)131.99 (04/17/2015)
Daily volume79,075
Average volume (3 months)159,391
Data as of 04/20/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+22.89%
Expense Gross exp ratio0.41%0.47%
Risk 5 year sharpe ratio--1.48
Net assets$770.7M$1.8B
Average market cap$37.5B$35.3B
Average P/E28.025.2
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences13.89%
AMGN Amgen12.01%
CELG Celgene10.82%
BIIB Biogen8.62%
REGN Regeneron Pharmaceuticals5.24%
BMRN Biomarin Pharmaceutical Inc4.79%
ILMN Illumina Inc4.34%
VRTX Vertex Pharmaceuticals Inc4.31%
ALXN Alexion Pharmaceuticals Inc4.30%
MDVN Medivation Inc4.03%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers